CNS relapse in acute promyeloctyic leukemia

J Clin Oncol. 2010 Aug 20;28(24):e409-11. doi: 10.1200/JCO.2009.27.1577. Epub 2010 Jun 7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Arsenic Trioxide
  • Arsenicals / administration & dosage
  • Bone Marrow Neoplasms / diagnosis*
  • Bone Marrow Neoplasms / genetics
  • Bone Marrow Neoplasms / therapy*
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / therapy*
  • Chromosomes, Human, Pair 15
  • Chromosomes, Human, Pair 17
  • Cranial Irradiation
  • Cytarabine / administration & dosage
  • Drug Administration Schedule
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Idarubicin / administration & dosage
  • Leukemia, Promyelocytic, Acute / diagnosis*
  • Leukemia, Promyelocytic, Acute / genetics
  • Leukemia, Promyelocytic, Acute / therapy*
  • Magnetic Resonance Imaging
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Mutation*
  • Nuclear Proteins / genetics
  • Oxides / administration & dosage
  • Promyelocytic Leukemia Protein
  • Receptors, Retinoic Acid / genetics
  • Recurrence
  • Remission Induction
  • Retinoic Acid Receptor alpha
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors / genetics
  • Translocation, Genetic
  • Transplantation, Autologous
  • Treatment Outcome
  • Tretinoin / administration & dosage
  • Tumor Suppressor Proteins / genetics
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • Arsenicals
  • Nuclear Proteins
  • Oxides
  • Promyelocytic Leukemia Protein
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Transcription Factors
  • Tumor Suppressor Proteins
  • Cytarabine
  • PML protein, human
  • Tretinoin
  • Mercaptopurine
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • Arsenic Trioxide
  • Methotrexate
  • Idarubicin